IONS - Ionis Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 59.65B
Enterprise Value 38.24B
Trailing P/E 25.91
Forward P/E 1264.46
PEG Ratio (5 yr expected) 1-5.52
Price/Sales (ttm)12.82
Price/Book (mrq)7.95
Enterprise Value/Revenue 310.95
Enterprise Value/EBITDA 6106.29

Trading Information

Stock Price History

Beta (3Y Monthly) 1.71
52-Week Change 358.08%
S&P500 52-Week Change 36.70%
52 Week High 386.58
52 Week Low 341.25
50-Day Moving Average 365.16
200-Day Moving Average 367.52

Share Statistics

Avg Vol (3 month) 31.33M
Avg Vol (10 day) 31.01M
Shares Outstanding 5140.32M
Float 127.63M
% Held by Insiders 19.13%
% Held by Institutions 185.90%
Shares Short (Jun 28, 2019) 415.47M
Short Ratio (Jun 28, 2019) 411.18
Short % of Float (Jun 28, 2019) 413.26%
Short % of Shares Outstanding (Jun 28, 2019) 411.03%
Shares Short (prior month May 31, 2019) 415.29M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 47.79%
Operating Margin (ttm)8.54%

Management Effectiveness

Return on Assets (ttm)1.94%
Return on Equity (ttm)35.69%

Income Statement

Revenue (ttm)752.47M
Revenue Per Share (ttm)5.55
Quarterly Revenue Growth (yoy)105.80%
Gross Profit (ttm)184.05M
EBITDA 77.53M
Net Income Avi to Common (ttm)365.62M
Diluted EPS (ttm)2.65
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.26B
Total Cash Per Share (mrq)16.08
Total Debt (mrq)668.08M
Total Debt/Equity (mrq)48.15
Current Ratio (mrq)9.40
Book Value Per Share (mrq)8.65

Cash Flow Statement

Operating Cash Flow (ttm)697.43M
Levered Free Cash Flow (ttm)205.75M